SARS-CoV-IN-1 is a potent inhibitor of SARS-CoV replication with antiviral activity (EC50 = 4.9 μM in Vero cells); it also exhibits antimalarial activity by inhibiting Plasmodium falciparum 3D7 and W2 strains (IC50 = 15.4 nM and 133.2 nM, respectively; IC90 = 25.7 nM and 459.1 nM, respectively), demonstrating superior in vitro efficacy against P. falciparum compared to chloroquine.